Losing 30 Pounds in 30 Days with New Weight Loss Discovery
Find your bikini body with a new medical procedure for weight loss that causes patients to lose nearly 30 pounds in the first 30 days.
Recent findings from a study presented at the American College of Cardiology's 62nd Annual Scientific Session and published in the medical journal JACC Cardiovascular Interventions reveals that a relatively minimally invasive surgical procedure called "gastric artery chemical embolization" inhibits the hunger hormone ghrelin and causes patients to lose nearly 30 pounds in the first 30 days following the surgery.
Gastric artery chemical embolization (GACE) is a well-known surgical procedure that involves implanting tiny beads to treat bleeding in the upper GI tract. However, past animal studies and current human studies show that when the procedure is used to place beads into the left gastric artery, that the blood supply to the gastric fundus―the upper region of the stomach responsible for the production of the hunger hormone ghrelin― is decreased along with the appetite inducing hormone. The result of this surgical procedure leads to rapid weight loss in both obese animals and humans.
A news report states that the authors of the study believe that this may be a new and better surgical procedure over other more-invasive Bariatric surgery procedures for weight loss.
"Weight loss is a major problem," said Nicholas Kipshidze, MD, PhD, who is with New York Cardiovascular Research, general director and physician in chief at Republican Hospital, Tbilisi, Georgia, and the study's lead investigator. "There are medications, but they have side effects. Bariatric surgery is well established, but it's a major surgery. This procedure may develop into a new, simple method for the treatment of obesity…it's a one day surgery," Dr. Kipshidze says. "You can do the procedure on patients in the morning and send them home in the evening."
In the study, 5 obese individuals with an average BMI of 42.3 were given the gastric artery chemical embolization procedure and then monitored afterward with an endoscope to insure there were no complications from the surgery. One month following the surgery the average BMI dropped to 37.9 with an average weight loss of 29.2 pounds.
Furthermore, the researchers found that the decrease in BMI and weight was paralleled with blood ghrelin levels having dropped an average of 29 percent from baseline measurements made prior to surgery. The only reported side effect was some initial discomfort shortly after surgery, but no evidence of tissue death due to the bead-occluded vessels.
The authors report that clinical studies comparing the weight loss surgical procedure to a placebo with a larger number of patients will be initiated in the near future.
Image Source: Courtesy of Morgue File
Reference: “CRT-88 Endovascular Treatment of Obesity: Early Results from First in Man Study” JACC Cardiovascular Interventions 2013; 6(2_S):S29-S29. doi:10.1016/j.jcin.2012.12.108; Nicholas Kipshidze; and Akaki Archvadze.